Articles related to MEDICAL BREAKTHROUGHS

Sanbexin’s sublingual formulation offers a potential paradigm shift in acute ischemic stroke treatment, enabling flexible administration outside traditional hospital settings.

Researchers have identified insufficient activation of the aryl hydrocarbon receptor (AHR) pathway as a key driver in lupus pathogenesis, offering a new target for therapeutic intervention.

Radiopharmaceuticals represent a burgeoning frontier in cancer treatment, offering targeted therapies that minimize collateral damage to healthy tissues.

In a landmark surgical endeavor, neurosurgeons have transferred sciatic nerve components from an amputated foot to the brachial plexus, showcasing the potential of neuroplasticity in restoring hand mobility.

Explore how metixene, a repositioned antiparkinsonian drug, emerges as a promising agent in treating metastatic breast cancer and brain metastases, redefining therapeutic approaches in oncology.

The discovery that dopaminergic synapses become dysfunctional before neuronal death occurs could open up new avenues for potential therapies.